New Research: 2 stocks to buy as Nifty50 heads towards 40,000
Here is the latest financial fact sheet of ELDER PHARMA. For more details, see the ELDER PHARMA quarterly results and ELDER PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 20.54 |
1 Week | % | 5.0 |
1 Month | % | 27.1 |
1 Year | % | -64.5 |
52 week H/L | Rs | 118.8/20.4 |
No. of Mths Year Ending |
12 Mar-10* |
12 Mar-11* |
12 Mar-12* |
12 Jun-13* |
12 Jun-14* |
5-Yr Chart Click to enlarge
|
---|
ELDER PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 383 | 440 | 435 | 474 | 380 | |
Low | Rs | 191 | 309 | 298 | 202 | 188 | |
Sales per share (Unadj.) | Rs | 379.1 | 465.2 | 644.9 | 793.4 | 489.2 | |
Earnings per share (Unadj.) | Rs | 25.0 | 30.9 | 35.2 | 40.1 | -3.2 | |
Diluted earnings per share | Rs | 23.0 | 30.9 | 35.2 | 40.1 | -3.2 | |
Cash flow per share (Unadj.) | Rs | 34.2 | 44.9 | 51.7 | 61.6 | 14.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 3.00 | 3.00 | 0 | 0 | |
Adj. dividends per share | Rs | 2.76 | 3.00 | 3.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 1.0 | 0.8 | 0.8 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 254.8 | 307.0 | 341.1 | 374.5 | 376.5 | |
Adj. book value per share | Rs | 234.0 | 307.1 | 341.1 | 374.6 | 376.6 | |
Shares outstanding (eoy) | m | 18.86 | 20.54 | 20.54 | 20.54 | 20.54 | |
Price / Sales ratio | x | 0.8 | 0.8 | 0.6 | 0.4 | 0.6 | |
Avg P/E ratio | x | 11.5 | 12.1 | 10.4 | 8.4 | -89.3 | |
P/CF ratio (eoy) | x | 8.4 | 8.3 | 7.1 | 5.5 | 19.7 | |
Price / Book Value ratio | x | 1.1 | 1.2 | 1.1 | 0.9 | 0.8 | |
Dividend payout | % | 12.0 | 9.7 | 8.5 | 0 | 0 | |
Avg Mkt Cap | Rs m | 5,412 | 7,693 | 7,527 | 6,943 | 5,832 | |
Total wages/salary | Rs m | 966 | 1,191 | 1,799 | 2,331 | 2,179 |
ELDER PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,149 | 9,555 | 13,245 | 16,296 | 10,048 | |
Other income | Rs m | 86 | 87 | 265 | 327 | 257 | |
Total revenues | Rs m | 7,235 | 9,642 | 13,511 | 16,623 | 10,305 | |
Gross profit | Rs m | 1,181 | 1,660 | 2,005 | 2,705 | 2,921 | |
Depreciation | Rs m | 172 | 287 | 340 | 441 | 361 | |
Interest | Rs m | 530 | 655 | 1,016 | 1,548 | 2,756 | |
Profit before tax | Rs m | 565 | 804 | 915 | 1,043 | 60 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 93 | 169 | 192 | 219 | 125 | |
Profit after tax | Rs m | 472 | 635 | 723 | 824 | -65 | |
Gross profit margin | % | 16.5 | 17.4 | 15.1 | 16.6 | 29.1 | |
Effective tax rate | % | 16.4 | 21.0 | 21.0 | 21.0 | 209.1 | |
Net profit margin | % | 6.6 | 6.7 | 5.5 | 5.1 | -0.6 |
ELDER PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,869 | 8,278 | 8,782 | 8,791 | 9,240 | |
Current liabilities | Rs m | 1,238 | 5,803 | 6,957 | 9,998 | 9,998 | |
Net working cap to sales | % | 64.8 | 25.9 | 13.8 | -7.4 | -7.5 | |
Current ratio | x | 4.7 | 1.4 | 1.3 | 0.9 | 0.9 | |
Inventory Days | Days | 34 | 68 | 67 | 146 | 128 | |
Debtors Days | Days | 997 | 1,079 | 941 | 892 | 602 | |
Net fixed assets | Rs m | 6,054 | 9,137 | 11,216 | 16,133 | 13,642 | |
Share capital | Rs m | 189 | 206 | 206 | 206 | 206 | |
"Free" reserves | Rs m | 4,616 | 6,101 | 6,800 | 7,487 | 7,528 | |
Net worth | Rs m | 4,805 | 6,307 | 7,006 | 7,693 | 7,733 | |
Long term debt | Rs m | 5,739 | 5,095 | 5,825 | 7,039 | 4,889 | |
Total assets | Rs m | 11,923 | 17,415 | 19,998 | 24,925 | 22,882 | |
Interest coverage | x | 2.1 | 2.2 | 1.9 | 1.7 | 1.0 | |
Debt to equity ratio | x | 1.2 | 0.8 | 0.8 | 0.9 | 0.6 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.7 | 0.7 | 0.4 | |
Return on assets | % | 8.4 | 7.4 | 8.7 | 9.5 | 11.8 | |
Return on equity | % | 9.8 | 10.1 | 10.3 | 10.7 | -0.8 | |
Return on capital | % | 10.4 | 12.8 | 15.0 | 17.6 | 22.3 | |
Exports to sales | % | 2.4 | 2.4 | 2.1 | 1.9 | 3.1 | |
Imports to sales | % | 4.2 | 3.7 | 2.3 | 1.8 | 0.4 | |
Exports (fob) | Rs m | 175 | 228 | 280 | 318 | 307 | |
Imports (cif) | Rs m | 298 | 351 | 306 | 290 | 43 | |
Fx inflow | Rs m | 175 | 228 | 280 | 318 | 307 | |
Fx outflow | Rs m | 345 | 388 | 334 | 361 | 125 | |
Net fx | Rs m | -170 | -160 | -54 | -43 | 181 |
ELDER PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -910 | 657 | 147 | 166 | 11,754 | |
From Investments | Rs m | -1,611 | -1,507 | -1,711 | -632 | -561 | |
From Financial Activity | Rs m | 1,843 | 2,734 | 433 | -39 | -6,762 | |
Net Cashflow | Rs m | -678 | 1,885 | 1,540 | 1,034 | 5,466 |
Share Holding
Shareholding as on Sep 2015
|
Company Information
|
CHM: Alok Jagdish Saxena | COMP SEC: Vijendra Jain | YEAR OF INC: 1983 | BSE CODE: 532322 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare ELDER PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.